Evonik reports strong second quarter

Evonik Reports Strong Second Quarter: Adjusted EBITDA Rises to €630 Million

Higher Volumes and Selling Prices Driven by Supply Chain Bottlenecks Outside Europe

Essen, Germany

Evonik delivered strong earnings in the second quarter of 2026, driven by an economic windfall from supply chain bottlenecks caused by the ongoing conflict in the Middle East. Adjusted EBITDA rose by 24 percent year-over-year to €630 million, prompting the company to significantly raise its full-year guidance. Evonik now expects adjusted EBITDA for fiscal 2026 to be between €2.0 billion and €2.2 billion (up from the previous €1.7 billion to €2.0 billion range).

Executive Insights and Efficiency Program Extension

Chief Executive Officer Christian Kullmann noted that while the strong quarter provides a welcome boost, fundamental industry challenges remain:

“We are witnessing a warm summer rain. But unfortunately, this does not change the fundamental challenges for our industry.”

— Christian Kullmann, CEO

To strengthen long-term competitiveness, Evonik is extending its “Evonik Tailor Made” efficiency program. An additional reduction of around 3,200 positions is planned for the 2027 to 2029 period, following earlier reductions under the 2024–2026 timeline.

Segment Performance Highlights

Advanced Technologies: Sales rose 9 percent to €1,647 million, backed by higher volumes and selling prices—particularly in Animal Nutrition and Organics, which benefited from global shipping disruptions around the Arabian Peninsula and the Strait of Hormuz. Adjusted EBITDA jumped 25 percent to €333 million.
Custom Solutions: Sales grew 4 percent to €1,422 million on higher demand for polyurethane foam additives, paints and coatings, and oil additives. Adjusted EBITDA increased 7 percent to €271 million.

“Improving debt ratios and creating future financial room to maneuver.”